Stay updated on Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.

Latest updates to the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedA new revision tag v3.6.0 was added to the study record history and the previous revision v3.5.5 was removed. New navigation items 'Check who can join' and 'Find Contact Information' appear on the page.SummaryDifference0.4%

- Check16 days agoChange DetectedAn additional revision entry, v3.5.5, has been added to the study history. The previous revision, v3.5.4, has been removed from the current listing.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision label updated to v3.5.4 in the Study Record Versions, replacing the previous v3.5.3. This update reflects a metadata change in the study history rather than substantive content.SummaryDifference0.1%

- Check59 days agoChange DetectedA minor update to the page’s internal revision/version label (from v3.5.2 to v3.5.3) without changing the study’s displayed record information.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded revision v3.5.2 to the history and removed the previous v3.5.0 entry.SummaryDifference0.1%

- Check95 days agoChange DetectedA new version entry (v3.5.0) was added with updates to Study Status and Contacts/Locations, and an older revision (v3.4.3) was removed.SummaryDifference0.4%

Stay in the know with updates to Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.